Scottsdale, Arizona (PRWEB) February 17, 2012
QualityStocks would like to highlight China Health Resource, Inc., a publicly traded company engaged in the development, manufacturing, processing, marketing, and sale of Dahurian Angelica Root (DAR) and related products in the People’s Republic of China. DAR, which is also known as “Bai Zhi” in Mandarin Chinese, is an herb that is employed as an ingredient in medicine, cosmetics, and food, as well as in TCM for the treatment of pain, swelling, and pustule. The company’s DAR-related products include the Bailing Capsule, Yisheng Capsule, Kimchee-Mate and Fragrant Bag, all of which are sold through regional distributors.
In the company’s news yesterday,
China Health Resource announced unaudited financial results for the fourth quarter and year ended December 31, 2011.
The company expects 2011 fourth-quarter operating revenues of more than $12.5 million, a 218 percent increase compared to the fourth quarter of 2010. For full year 2011, the company expects operating revenues of $34.9 million, a 241 percent increase over 2010 revenues.
China Health expects 2011 fourth-quarter net income to be $2.7 million, or $0.015 per fully diluted common share, compared with $1.6 million or $0.01 per share, reported for the fourth quarter of 2010. For full year 2011, the company anticipates net income of $6.8 million, or $0.038 per fully diluted common share, compared with a net income of$2.7 million, or $0.02 per share in the year prior.
The company attributes its growth to the expansion of its TCM product lines, improvements in sales channel management to extend market reach, and consistent cost controls.
China Health also provided guidance for 2012 with a focus on growing its product lines and implementing further growth initiatives.
The company anticipates 2012 earnings in the range of $0.06 and $0.065 per share.
Jiayin Wang, President and CEO of CHRI, stated, “Speaking to the company’s focus in 2012, we will continue to maintain our leadership in our DAR franchise while we grow our product lines with valuable and high growth products like Gastrodiae. In addition, we will pursue growth opportunities worldwide through acquisition and distribution and grow in areas where we can best serve customers and create value.”
China Health said it will provide detailed results in its final 2011 fourth quarter and year-end earnings press release and 10-K filing.
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for The QualityStocks Daily Newsletter, please visit http://www.QualityStocks.net
To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage
To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks
Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.